雷科防務(002413.SZ):半年度預虧4000萬元–6000萬元
格隆匯7月11日丨雷科防務(002413.SZ)公佈2025年半年度業績預告,1-6月公司實現歸屬於上市公司股東的淨利潤虧損4,000萬元–6,000萬元,上年同期虧損6,642.59萬元;扣除非經常性損益後的淨利潤虧損4,800萬元–7,200萬元,上年同期虧損7,282.62萬元;基本每股收益虧損0.03元/股–0.05元/股;營業收入50,000萬元-60,000萬元。
報告期部分應收賬款賬齡延長,公司基於會計政策對存量應收賬款計提信用減值損失。基於2025年上半年的經營狀況以及對期末資產可變現淨值的測算,報告期公司擬計提存貨跌價準備等資產減值準備,預計對報告期損益造成影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.